Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debashis Sarker

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
Clinical Lymphoma|October 15, 2003
Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapyChristina Thirlwell, Debashis Sarker, Justin Stebbing, et al.
Clinical and Translational Radiation Oncology|September 3, 2020
The eIF4A inhibitor silvestrol sensitizes T-47D ductal breast carcinoma cells to external-beam radiotherapyThomas E Webb, Marc Davies, John Maher, et al.
Oncotarget|November 16, 2016
Deciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer?Kiruthikah Thillai, Hoyin Lam, Debashis Sarker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Antiapoptotic effect of growth factors in leukemiaWai M Liu, Richard Baird, Debashis Sarker, et al.
Critical Reviews in Oncology/Hematology|January 17, 2015
The role of the PI3K pathway in colorectal cancerDionysios Papadatos-Pastos, Roy Rabbie, Paul Ross, et al.
British Journal of Cancer|March 24, 2023
Revitalising cancer trials post-pandemic: time for reformCienne Morton, Richard Sullivan, Debashis Sarker, et al.
Medicine International|January 30, 2026
Multimodal treatment and tumour biology-driven long-term survival in PSC-associated hilar cholangiocarcinoma: A case reportEvangelia Florou, Michael Heneghan, Debashis Sarker, et al.
Expert Review of Anticancer Therapy|September 11, 2014
FOLFIRINOX - a new paradigm in the treatment of pancreatic cancerDionysios Papadatos-Pastos, Kiruthikah Thillai, Roy Rabbie, et al.
Cells|August 7, 2021
Apoptosis in the Pancreatic Cancer Tumor Microenvironment-The Double-Edged Sword of Cancer-Associated FibroblastsEster Pfeifer, Joy M Burchell, Francesco Dazzi, et al.
Virchows Archiv : an International Journal of Pathology|July 15, 2017
Histological heterogeneity in primary and metastatic classic combined hepatocellular-cholangiocarcinoma: a case seriesClaudio De Vito, Debashis Sarker, Paul Ross, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Clinical Lymphoma|October 15, 2003
Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapyChristina Thirlwell, Debashis Sarker, Justin Stebbing, et al.
Clinical and Translational Radiation Oncology|September 3, 2020
The eIF4A inhibitor silvestrol sensitizes T-47D ductal breast carcinoma cells to external-beam radiotherapyThomas E Webb, Marc Davies, John Maher, et al.
Oncotarget|November 16, 2016
Deciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer?Kiruthikah Thillai, Hoyin Lam, Debashis Sarker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Antiapoptotic effect of growth factors in leukemiaWai M Liu, Richard Baird, Debashis Sarker, et al.
Critical Reviews in Oncology/Hematology|January 17, 2015
The role of the PI3K pathway in colorectal cancerDionysios Papadatos-Pastos, Roy Rabbie, Paul Ross, et al.
British Journal of Cancer|March 24, 2023
Revitalising cancer trials post-pandemic: time for reformCienne Morton, Richard Sullivan, Debashis Sarker, et al.
Medicine International|January 30, 2026
Multimodal treatment and tumour biology-driven long-term survival in PSC-associated hilar cholangiocarcinoma: A case reportEvangelia Florou, Michael Heneghan, Debashis Sarker, et al.
Expert Review of Anticancer Therapy|September 11, 2014
FOLFIRINOX - a new paradigm in the treatment of pancreatic cancerDionysios Papadatos-Pastos, Kiruthikah Thillai, Roy Rabbie, et al.
Cells|August 7, 2021
Apoptosis in the Pancreatic Cancer Tumor Microenvironment-The Double-Edged Sword of Cancer-Associated FibroblastsEster Pfeifer, Joy M Burchell, Francesco Dazzi, et al.
Virchows Archiv : an International Journal of Pathology|July 15, 2017
Histological heterogeneity in primary and metastatic classic combined hepatocellular-cholangiocarcinoma: a case seriesClaudio De Vito, Debashis Sarker, Paul Ross, et al.
Pageof 8